Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

TPEX:4111 Revenue

Chi Sheng Pharma & Biotech had revenue of 342.14M TWD in the quarter ending September 30, 2025, with 20.36% growth. This brings the company's revenue in the last twelve months to 1.36B, up 23.28% year-over-year. In the year 2024, Chi Sheng Pharma & Biotech had annual revenue of 1.17B with 9.86% growth.

• Revenue (ttm): 1.36B
• Revenue Growth: +23.28%
• P/S Ratio: 1.31
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.17B	104.57M	9.86%
Dec 31, 2023	1.06B	-82.21M	-7.19%
Dec 31, 2022	1.14B	120.78M	11.81%
Dec 31, 2021	1.02B	42.94M	4.38%
Dec 31, 2020	979.36M	-43.60M	-4.26%